MeSH term
Frequency | Condition_Probility | Adult | 6 | 0.0 |
Humans | 81 | 0.0 |
Male | 12 | 0.0 |
Middle Aged | 9 | 0.0 |
Reference Values | 2 | 0.0 |
Animals | 38 | 0.0 |
Apolipoproteins E/genetics | 2 | 0.0 |
Cells, Cultured | 16 | 0.0 |
Growth Substances/*biosynthesis/genetics | 2 | 7.0 |
Immediate-Early Proteins/*biosynthesis/genetics | 3 | 23.0 |
*Intercellular Signaling Peptides and Proteins | 35 | 6.0 |
Mice | 23 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Rats | 11 | 0.0 |
*Up-Regulation | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 10 | 0.0 |
Cell Adhesion/physiology | 4 | 1.0 |
Disease Models, Animal | 2 | 0.0 |
Growth Substances/*metabolism | 4 | 2.0 |
Immunohistochemistry | 5 | 0.0 |
Protein Binding | 9 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 39 | 0.0 |
Female | 14 | 0.0 |
Flow Cytometry | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
*Immediate-Early Proteins | 9 | 3.0 |
Tumor Cells, Cultured | 13 | 0.0 |
Comparative Study | 9 | 0.0 |
Estradiol/*analogs & derivatives/pharmacology | 2 | 4.0 |
Genes, Immediate-Early | 2 | 3.0 |
Phenotype | 2 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 10 | 0.0 |
Tamoxifen/pharmacology | 2 | 2.0 |
Transfection | 10 | 0.0 |
Tumor Cells, Cultured/drug effects/metabolism/pathology | 2 | 5.0 |
Base Sequence | 10 | 0.0 |
Fibroblasts/*metabolism | 3 | 1.0 |
Gene Expression | 6 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Carrier Proteins/metabolism | 4 | 0.0 |
Cattle | 2 | 0.0 |
Cell Division | 9 | 0.0 |
Cell Line | 12 | 0.0 |
Culture Media, Conditioned/pharmacology | 2 | 1.0 |
Culture Media, Serum-Free/pharmacology | 2 | 1.0 |
Dose-Response Relationship, Drug | 7 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Ligands | 3 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Swine | 3 | 0.0 |
Blotting, Northern | 8 | 0.0 |
Blotting, Western | 4 | 0.0 |
Cell Cycle | 3 | 0.0 |
DNA, Complementary/metabolism | 4 | 0.0 |
Growth Substances/*genetics/*metabolism | 2 | 33.0 |
Immediate-Early Proteins/*genetics/*metabolism | 2 | 33.0 |
Mice, Nude | 4 | 0.0 |
Neoplasm Transplantation | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
RNA/metabolism | 4 | 0.0 |
Time Factors | 8 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Up-Regulation | 7 | 0.0 |
Cell Adhesion | 8 | 0.0 |
Cell Movement | 5 | 0.0 |
Cell Survival | 4 | 0.0 |
Down-Regulation | 3 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Immunoblotting | 2 | 0.0 |
Insects | 2 | 1.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 3 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Models, Biological | 4 | 0.0 |
*Neovascularization, Physiologic | 4 | 2.0 |
Oligonucleotide Array Sequence Analysis | 6 | 0.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
Skin/*metabolism | 2 | 1.0 |
Vascular Endothelial Growth Factor A | 7 | 0.0 |
Vascular Endothelial Growth Factor C | 2 | 2.0 |
Chickens | 2 | 0.0 |
*Cyclins | 2 | 10.0 |
*Drosophila Proteins | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
DNA Primers | 3 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Antibodies/pharmacology | 2 | 0.0 |
Epidermal Growth Factor/pharmacology | 2 | 0.0 |
Estrogen Antagonists/pharmacology | 2 | 2.0 |
In Situ Hybridization | 3 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Kinetics | 6 | 0.0 |
Neovascularization, Physiologic/*physiology | 3 | 2.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Umbilical Veins | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 6 | 0.0 |
Immediate-Early Proteins/genetics/*metabolism | 4 | 7.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Disease Progression | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Immediate-Early Proteins/*biosynthesis | 2 | 28.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Cell Division/*physiology | 2 | 1.0 |
Cell Movement/physiology | 3 | 1.0 |
Immediate-Early Proteins/*metabolism | 5 | 8.0 |
Mutagenesis | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Integrins/metabolism | 2 | 1.0 |
Precipitin Tests | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Signal Transduction | 5 | 0.0 |
Wound Healing/physiology | 2 | 3.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Growth Substances/*genetics | 4 | 3.0 |
Immediate-Early Proteins/*genetics | 8 | 12.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Transcription, Genetic | 6 | 0.0 |
DNA, Complementary | 4 | 0.0 |
Gene Expression Regulation/*physiology | 3 | 0.0 |
Immediate-Early Proteins/genetics/*physiology | 2 | 18.0 |
RNA, Messenger/genetics | 2 | 0.0 |
*Signal Transduction | 4 | 0.0 |
*Protein Biosynthesis | 2 | 0.0 |
Growth Substances/genetics | 2 | 3.0 |
Hela Cells | 3 | 0.0 |
Immediate-Early Proteins/genetics | 2 | 4.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Immediate-Early Proteins/*physiology | 3 | 11.0 |
Endothelium, Vascular/cytology/*physiology | 3 | 4.0 |
Cloning, Molecular | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Receptors, Vitronectin/*physiology | 2 | 50.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Drug Synergism | 2 | 0.0 |
Cell Line, Tumor | 7 | 0.0 |
*Gene Expression Profiling | 3 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
*Apoptosis | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Paclitaxel/pharmacology | 2 | 2.0 |
Intercellular Signaling Peptides and Proteins/*genetics | 5 | 8.0 |
Intercellular Signaling Peptides and Proteins/*metabolism | 2 | 2.0 |
Intercellular Signaling Peptides and Proteins/genetics/*metabolism | 3 | 9.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Reference Standards | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/genetics | 2 | 1.0 |
Neovascularization, Pathologic/*physiopathology | 2 | 2.0 |
Culture Media | 2 | 0.0 |
In Vitro | 4 | 0.0 |
*Oncogene Proteins | 2 | 3.0 |
Gene Expression Profiling | 2 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Immediate-Early Proteins/*genetics/metabolism | 3 | 30.0 |
Intercellular Signaling Peptides and Proteins/*genetics/metabolism | 3 | 20.0 |
Vascular Endothelial Growth Factors | 6 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Intercellular Signaling Peptides and Proteins/*physiology | 2 | 7.0 |
Neoplasm Invasiveness | 2 | 0.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
